Lowest Price Guaranteed From USD 4,799
Published
April 2023
Slides
231
View Count
9339
Example Insights
Available on request
Report Description
The global lab automation market is estimated to be worth $5.5 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9.3% during the forecast period. Owing to the growing demand for complex biopharmaceuticals, the number of laboratories providing analytical and product development solutions has increased significantly across the globe. During each step of a laboratory process, it is essential to ensure that all the variables and parameters are under control. However, there are several challenges associated with conventional and manual handling, such as the high risk of sample contamination, high labor costs, time management, operator-to-operator variations and lack of real-time data availability. According to a research article published by Nature, over 70% of scientists were unable to replicate a previously published experiment. This has created a demand for instruments that can reduce the chances of errors, save time and money and boost reproducibility. As a result, lab automation has emerged as the most suitable alternative since it has the ability to overcome the issues associated with manual handling. By eliminating laborious and repetitive processes in the lab, automated technologies enable researchers to focus more on specialized operations. Also, automated sampling systems offer various additional benefits including real-time data monitoring, reduction in deviations by around 65% and increase in the overall productivity up to 80%. Additionally, lab automation minimizes the risk of human errors while maintaining data accuracy and traceability. We believe that the lab automation market will grow significantly in the coming years, owing to significant advancements and the fact that lab automation and related modules can be customized to meet individual needs.
![]() |
![]() |
![]() |
The Lab Automation Market: Distribution by Stage of Automation (Pre-analytical Stage, Analytical Stage, Post-Analytical Stage and Total Lab Automation), Type of Instrument (Automated Liquid Handling Systems, Automated Microplate Readers, Automated Sampling Systems, Analyzers, Automated Storage and Retrieval Systems (ASRS) and Other Instruments), Application (Diagnostics, Genomic Solutions, Microbiology, Drug Discovery, Proteomic Solutions and Other Applications), End-user (Pharmaceutical and Biotechnology Companies, Research and Diagnostic Laboratories and Other End-Users) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and future potential of the lab automation market, over the next 12 years. It highlights the efforts of various stakeholders engaged in this rapidly emerging segment of the process equipment industry. The report answers many key questions related to this domain.
Lab automation refers to the use of any equipment or device that may execute tasks in the lab with little or no hands-on engagement from professionals. It is one of the rapidly emerging concepts that involves integration of automated technologies into laboratories to enhance operations, including pipetting and data analysis, involved in various day-to-day laboratory practices. Lab automation devices, such as automated liquid handling systems have several advantages, including the ability to simplify sample preparation while maintaining consistent high accuracy and allowing labs to free up manual labor and run more samples along with maintaining reproducibility. Further, automated storage and retrieval systems (ASRS) lower down the variable cost of operations by eliminating the need for manual labor for tasks such as picking, storing, assembly and inventory replenishment. This increases the level of accountability and security preventing inventory shrinkage and allowing to locate missing or misplaced items. It is worth highlighting that large-scale automation employing robotic workstations is generally used in clinical, pharmaceutical and life science labs, where a large number of tests and studies are conducted on a daily basis.
The lab automation market is among the most promising domains in the healthcare industry. Currently, around 350 companies have the required capabilities to manufacture lab automation system. Notably, at present, around 50% of these lab automation system manufacturers are focusing on automated liquid handling systems, as it reduces the chances of human error in the pre-analytical stage of diagnostics, where most of the error occurs.
![]() |
![]() |
![]() |
The use of automated storage and retrieval systems (ASRS) allows an operator to have better inventory control. In the case of manual inventory control, an operator must check the inventory on a regular basis to obtain pertinent information. Automated storage and retrieval systems (ASRS) keep the inventory safe, secure and under control by enclosing it in a fully enclosed system. This assist to track missing or misplaced goods which increases level of accountability and security preventing inventory shrinkage.
In recent years, several partnerships have been inked by various stakeholders in order to consolidate their presence in this field and enhance their capabilities and product portfolio to meet the growing demand for lab automation systems. Acquisitions, product development agreements and distribution agreements are the most common types of partnerships inked by stakeholders in the lab automation domain. Further, majority of such partnerships are focused on various automation instruments, including automated data analysis, automated liquid handling systems and total lab automation.
Over 6,200 patents focused on lab automation have been granted / filed in the past six years, indicating the substantial efforts made by researchers engaged in this domain. Primarily, most of the patents have been filed to advance research on various components of lab automation systems, such as samples, labels, devices and tests.
Driven by enhanced productivity and improved timelines, lucrative opportunities are expected to emerge for players developing lab automation systems. The global lab automation market is anticipated to grow at a significant pace, with a CAGR of around 10% during the period 2023-2035. Among the stages of automation, the pre-analytical stage is most likely to adopt lab automation because it has the highest risk of error during laboratory diagnostics. in terms of geography, the lab automation market in Asia-Pacific is likely to grow at a relatively faster pace in the long term.
Automated liquid handling systems are anticipated to capture the largest share of the market. Liquid handling systems have seen increased adoption in not only the pharma and biotech laboratories, but also academic laboratories. With this, automated liquid handling technology is constantly improving and players are integrating the advanced features. Recently, Microlab STAR Liquid Handling System by Hamilton has been awarded as 2022 Good Design Award by The Chicago Athenaeum: Museum of Architecture and Design and The European Centre for Architecture Art Design and Urban Studies. In this new automated liquid handling system, Hamilton integrates innovative functions, flexibility, and ease of use in a minimalistic and transparent appearance.
Examples of the key players in this domain (the complete list of players is available in the full report) include (in alphabetic order) Abbott, Anton Paar, BD, Beckman Coulter, ERWEKA, Leuze, Ortho Clinical Diagnostics, Pall Corporation, PerkinElmer, Roche Diagnostics, Siemens Healthineers and SYSTAG.
![]() |
![]() |
![]() |
Several recent developments have taken place in the field of lab automation. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
The market report presents an in-depth analysis of the various firms / organizations that are engaged in this industry, across different segments as defined in the table below:
Key Report Attributes | Details | |
Base Year |
2022 |
|
Forecast Period |
2023 – 2035 |
|
Historical Trends |
2018-2022 |
|
Market Size 2023 |
$ 5.5 Billion |
|
CAGR |
|
|
Stage of Automation |
|
|
Type of Instrument |
|
|
Application |
|
|
End-User |
|
|
Key Geographical Regions |
|
|
Key Companies Profiled |
|
|
Customization Scope |
|
|
PowerPoint Presentation (Complimentary) |
|
|
Excel Data Packs (Complimentary) |
|
Amongst other elements, the report includes:
One of the key objectives of the report was to evaluate the current opportunity and future growth potential associated with the lab automation market, over the coming years. We have provided informed estimates on the likely evolution of the market in the mid-to-long term for the period 2023-2035. Our year-wise projections of the current and future opportunity have been further segmented based on relevant parameters, such as stage of automation (pre-analytical stage, analytical stage, post-analytical stage and total lab automation), type of instrument (automated liquid handling systems, automated microplate readers, automated sampling systems, analyzers, automated storage and retrieval systems (ASRS) and other instruments), application (diagnostics, genomic solutions, microbiology, drug discovery, proteomic solutions and other applications), end-user (pharmaceutical and biotechnology companies, research and diagnostic laboratories and other end-users) and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s evolution.
The opinions and insights presented in the report were influenced by discussions held with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
![]() |
![]() |
![]() |
Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Overview of Lab Automation
3.2. Historical Evolution of Lab Automation
3.3. Stages of Lab Automation
3.4. Process of Lab Automation
3.5. Advantages of Lab Automation Over Manual Handling
3.6. Challenges associated with Lab Automation
3.7. Future Perspectives
4. MARKET LANDSCAPE
4.1. Lab Automation System Manufacturers: Overall Market Landscape
4.1.1. Analysis by Year of Establishment
4.1.2. Analysis by Company Size
4.1.3. Analysis by Location of Headquarters
4.1.4. Analysis by Company Size and Location of Headquarters
4.1.5. Analysis by Type of Lab Automation System(s)
4.1.6. Analysis by Type of Automated Liquid Handler(s)
4.1.7. Analysis by Type of Automated Microplate(s)
4.1.8. Analysis by Stage(s) of Automation
4.1.9. Analysis by Application Area(s)
4.1.10. Analysis by Type of Lab Automation System(s) and Application Area(s)
4.1.11. Analysis by End-user(s)
4.1.12. Analysis by Stage(s) of Automation and End-user(s)
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Assumptions and Key Parameters
5.2 Methodology
5.3. Competitiveness Analysis: Very Small Companies based in North America (Peer Group I)
5.4. Competitiveness Analysis: Small Companies based in North America (Peer Group II)
5.5 Competitiveness Analysis: Mid-sized Players based in North America (Peer Group III)
5.5. Competitiveness Analysis: Large Companies based in North America (Peer Group IV)
5.6. Competitiveness Analysis: Very Large Companies based in North America (Peer Group V)
5.7 Competitiveness Analysis: Very Small Companies based in Europe (Peer Group VI)
5.8 Competitiveness Analysis: Small Companies based in Europe (Peer Group VII)
5.9. Competitiveness Analysis: Mid-sized Companies based in Europe (Peer Group VII)
5.10. Competitiveness Analysis: Large Companies based in Europe (Peer Group IX)
5.11. Competitiveness Analysis: Very Large Companies based in Europe (Peer Group X)
5.12. Competitiveness Analysis: Very Small Companies based in Asia-Pacific and Rest of the World (Peer Group XI)
5.13. Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World (Peer Group XII)
5.14. Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World (Peer Group XIII)
5.15. Competitiveness Analysis: Large Companies based in Asia-Pacific and Rest of the World (Peer Group XIV)
5.16. Competitiveness Analysis: Very Large Companies based in Asia-Pacific and Rest of the World (Peer Group XV)
6. COMPANY PROFILES
6.1. Abbott
6.1.1. Company Overview
6.1.2. Financial Information
6.1.3. Lab Automation Product Portfolio
6.1.4. Recent Developments and Future Outlook
6.2. Anton Paar
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Lab Automation Product Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. BD
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Lab Automation Product Portfolio
6.3.4. Recent Developments and Future Outlook
6.4. Beckman Coulter
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Lab Automation Product Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. ERWEKA
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Lab Automation Product Portfolio
6.5.4. Recent Developments and Future Outlook
6.6. Leuze
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Lab Automation Product Portfolio
6.6.4. Recent Developments and Future Outlook
6.7. Ortho Clinical Diagnostics
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Lab Automation Product Portfolio
6.7.4. Recent Developments and Future Outlook
6.8. Pall Corporation
6.8.1. Company Overview
6.8.2. Financial Information
6.8.3. Lab Automation Product Portfolio
6.8.4. Recent Developments and Future Outlook
6.9. PerkinElmer
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. Lab Automation Product Portfolio
6.9.4. Recent Developments and Future Outlook
6.10. Roche Diagnostics
6.10.1. Company Overview
6.10.2. Financial Information
6.10.3. Lab Automation Product Portfolio
6.10.4. Recent Developments and Future Outlook
6.11. Siemens Healthineers
6.11.1. Company Overview
6.11.2. Financial Information
6.11.3. Lab Automation Product Portfolio
6.11.4. Recent Developments and Future Outlook
6.12. SYSTAG
6.12.1. Company Overview
6.12.2. Financial Information
6.12.3. Lab Automation Product Portfolio
6.12.4. Recent Developments and Future Outlook
7. CASE STUDY: LAB AUTOMATION SOFTWARE
7.1. Lab Automation Software Providers: Overall Market Landscape
7.1.1. Analysis by Year of Establishment
7.1.2. Analysis by Company Size
7.1.3. Analysis by Location of Headquarters
7.1.4. Analysis by Company Size and Location of Headquarters
7.1.5. Analysis by Type of Software
7.1.6. Analysis by Mode(s) of Deployment
7.1.7. Analysis by Type of Software and Mode(s) of Deployment
7.1.8. Analysis by End-user(s)
7.1.9. Analysis by Type of Software and End-user(s)
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Partnership Models
8.2. Lab Automation: List of Partnerships and Collaborations
8.2.1. Analysis by Year of Partnership
8.2.2. Analysis by Type of Partnership
8.2.3. Analysis by Year and Type of Partnership
8.2.4. Analysis by Type of Partner
8.2.5. Analysis by Year of Partnership and Type of Partner
8.2.6. Analysis by Type of Partnership and Type of Partner
8.2.7. Analysis by Type of Automation Instrument(s)
8.2.8. Analysis by Type of Partnership and Automation Instrument(s)
8.2.9. Most Active Players: Analysis by Number of Partnerships
8.2.10. Analysis by Geography
8.2.10.1. Local and International Agreements
8.2.10.2. Intracontinental and Intercontinental Agreements
9. PATENT ANALYSIS
9.1. Methodology and Key Parameters
9.2. Lab Automation: List of Patents
9.3. Analysis by Patent Publication Year
9.4. Analysis by Publication Year and Type of Patent
9.5. Analysis by Application Year
9.6. Analysis by Patent Jurisdiction
9.7. Analysis by CPC Symbols
9.8. Analysis by Type of Applicant
9.9. Word Cloud: Emerging Focus Areas
9.10. Analysis by Patent Age
9.11. Leading Industry Players: Analysis by Number of Patents
9.12. Leading Non-Industry Players: Analysis by Number of Patents
9.13. Leading Individual Assignees: Analysis by Number of Patents
9.14. Patent Benchmarking: Analysis of Leading Industry Players by Patent Characterization (CPC Symbols)
9.15. Patent Valuation: Methodology and Key Parameters
9.15.1. Analysis by Relative Patent Valuation
10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Methodology and Key Assumptions
10.2. Global Lab Automation Market, 2023-2035
10.2.1. Lab Automation Market: Distribution by Stage of Automation, 2023 and 2035
10.2.1.1. Lab Automation Market for Pre-analytical Stage, 2023-2035
10.2.1.2. Lab Automation Market for Analytical Stage, 2023-2035
10.2.1.3. Lab Automation Market for Post-analytical Stage, 2023-2035
10.2.1.4. Lab Automation Market for Total Lab Automation, 2023-2035
10.2.2. Lab Automation Market: Distribution by Type of Instrument, 2023 and 2035
10.2.2.1. Lab Automation Market for Automated Liquid Handling Systems, 2023-2035
10.2.2.2. Lab Automation Market for Automated Microplate Readers, 2023-2035
10.2.2.3. Lab Automation Market for Automated Sampling Systems, 2023-2035
10.2.2.4. Lab Automation Market for Analyzers, 2023-2035
10.2.2.5. Lab Automation Market for Automated Storage and Retrieval Systems (ASRS), 2023-2035
10.2.2.6. Lab Automation Market for Other Instruments, 2023-2035
10.2.3. Lab Automation Market: Distribution by Application, 2023 and 2035
10.2.3.1. Lab Automation Market for Diagnostics, 2023-2035
10.2.3.2. Lab Automation Market for Genomic Solutions, 2023-2035
10.2.3.3. Lab Automation Market for Microbiology, 2023-2035
10.2.3.4. Lab Automation Market for Drug Discovery, 2023-2035
10.2.3.5. Lab Automation Market for Proteomic Solutions, 2023-2035
10.2.3.6. Lab Automation Market for Other Applications, 2023-2035
10.2.4. Lab Automation Market: Distribution by End-user, 2023 and 2035
10.2.4.1. Lab Automation Market for Research and Diagnostic Laboratories, 2023-2035
10.2.4.2. Lab Automation Market for Biotechnology and Pharmaceutical Industries, 2023-2035
10.2.4.3. Lab Automation Market for Other End-users, 2023-2035
10.2.5. Lab Automation Market: Distribution by Key Geographical Regions,2023 and 2035
10.2.5.1. Lab Automation Market in North America, 2023-2035
10.2.5.2. Lab Automation Market in Europe, 2023-2035
10.2.5.3. Lab Automation Market in Asia-Pacific, 2023-2035
10.2.5.4. Lab Automation Market in Middle East and North Africa, 2023-2035
10.2.5.5. Lab Automation Market in Latin America, 2023-2035
11. EXECUTIVE INSIGHTS
11.1. Chapter Overview
11.2. Africa Medical Supplies Platform
11.2.1. Company Overview
11.2.2. Interview Transcript: Abiodun Sina-Olulana (Production and Supply Management Lead)
11.3. A.S.T. Biomedical
11.3.1. Company Overview
11.3.2. Interview Transcript: Barcella Mauro (Chief Executive Officer)
11.4. Berthold Technologies
11.4.1. Company Overview
11.4.2. Interview Transcript: Anonymous
11.5. Efevre Tech
11.5.1. Company Overview
11.5.2. Interview Transcript: Dimitris Kyriakou (Project Manager and Business Development)
11.6. HSE
11.6.1. Company Overview
11.6.2. Interview Transcript: Patrick Widler (Chief Commercial Officer)
11.7. Inheco
11.7.1. Company Overview
11.7.2. Interview Transcript: Daniel von Sierakowski (Account Manager)
11.8. LabWare
11.8.1. Company Overview
11.8.2. Interview Transcript: Mayookh Sengupta (Sales Manager)
11.9. SciRobotics
11.9.1. Company Overview
11.9.2. Interview Transcript: Shai Kaplan (Co-Founder and Co-Chief Executive Officer)
12. APPENDIX I: TABULATED DATA
13. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Overall Market Landscape of Lab Automation System Manufacturers
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Patent Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Historical Evolution of Lab Automation
Figure 3.2 Process Involved in Lab Automation
Figure 3.3 Advantages of Lab Automation Over Manual Handling
Figure 4.1 Lab Automation System Manufacturers: Distribution by Year of Establishment
Figure 4.2 Lab Automation System Manufacturers: Distribution by Company Size
Figure 4.3 Lab Automation System Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 4.4 Lab Automation System Manufacturers: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Lab Automation System Manufacturers: Distribution by Company Size and Location of Headquarters (Region-wise)
Figure 4.6 Lab Automation System Manufacturers: Distribution by Type of Lab Automation System(s)
Figure 4.7 Lab Automation System Manufacturers: Distribution by Type of Automated Liquid Handling System(s)
Figure 4.8 Lab Automation System Manufacturers: Distribution by Type of Automated Microplate(s)
Figure 4.9 Lab Automation System Manufacturers: Distribution by Stage(s) of Automation
Figure 4.10 Lab Automation System Manufacturers: Distribution by Application Area(s)
Figure 4.11 Lab Automation System Manufacturers: Distribution by Type of Lab Automation system(s) and Application Area(s)
Figure 4.12 Lab Automation System Manufacturers: Distribution by End-user(s)
Figure 4.13 Lab Automation System Manufacturers: Distribution by Stage(s) of Automation and End-user(s)
Figure 5.1 Company Competitiveness Analysis: Very Small Companies based in North America (Peer Group I)
Figure 5.2 Company Competitiveness Analysis: Small Companies based in North America (Peer Group II)
Figure 5.3 Company Competitiveness Analysis: Mid-sized Players based in North America (Peer Group III)
Figure 5.4 Company Competitiveness Analysis: Large Companies based in North America (Peer Group IV)
Figure 5.5 Company Competitiveness Analysis: Very Large Companies based in North America (Peer Group V)
Figure 5.6 Company Competitiveness Analysis: Very Small Companies based in Europe (Peer Group VI)
Figure 5.7 Company Competitiveness Analysis: Small Companies based in Europe (Peer Group VII)
Figure 5.8 Company Competitiveness Analysis: Mid-sized Companies based in Europe (Peer Group VIII)
Figure 5.9 Company Competitiveness Analysis: Large Companies based in Europe (Peer Group IX)
Figure 5.10 Company Competitiveness Analysis: Very Large Companies based in Europe (Peer Group X)
Figure 5.11 Company Competitiveness Analysis: Very Small Companies based in Asia-Pacific and Rest of the World (Peer Group XI)
Figure 5.12 Company Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World (Peer Group XII)
Figure 5.13 Company Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World (Peer Group XIII)
Figure 5.14 Company Competitiveness Analysis: Large Companies based in Asia-Pacific and Rest of the World (Peer Group XIV)
Figure 5.15 Company Competitiveness Analysis: Very Large Companies based in Asia-Pacific and Rest of the World (Peer Group XV)
Figure 6.1 Abbott: Annual Revenues, 2018-2022 (USD Billion)
Figure 6.2 Abbott: Product Portfolio
Figure 6.3 Anton Paar: Product Portfolio
Figure 6.4 BD: Annual Revenues, FY 2018-Q1 FY 2023 (USD Billion)
Figure 6.5 BD: Product Portfolio
Figure 6.6 Danaher (Parent Company of Beckman Coulter): Annual Revenues, FY 2018-FY 2022 (USD Billion)
Figure 6.7 Beckman Coulter: Product Portfolio
Figure 6.8 ERWEKA: Product Portfolio
Figure 6.9 Leuze: Product Portfolio
Figure 6.10 Ortho Clinical Diagnostics: Annual Revenues, FY 2019-FY 2022 (USD Billion)
Figure 6.11 Ortho Clinical Diagnostics: Product Portfolio
Figure 6.12 Danaher (Parent Company of Pall Corporation): Annual Revenues, FY 2018-FY 2022 (USD Billion)
Figure 6.13 Pall Corporation: Product Portfolio
Figure 6.14 PerkinElmer: Annual Revenues, FY 2018-FY 2022 (USD Billion)
Figure 6.15 PerkinElmer: Product Portfolio
Figure 6.16 Roche Diagnostics: Annual Revenues, FY 2018-FY 2022 (CHF Billion)
Figure 6.17 Roche Diagnostics: Product Portfolio
Figure 6.18 Siemens Healthineers: Annual Revenues, FY 2018-Q1 FY 2023 (Euro Billion)
Figure 6.19 Siemens Healthineers: Product Portfolio
Figure 6.20 SYSTAG: Product Portfolio
Figure 7.1 Lab Automation Software Providers: Distribution by Year of Establishment
Figure 7.2 Lab Automation Software Providers: Distribution by Company Size
Figure 7.3 Lab Automation Software Providers: Distribution by Location of Headquarters (Region-wise)
Figure 7.4 Lab Automation Software Providers: Distribution by Location of Headquarters (Country-wise)
Figure 7.5 Lab Automation Software Providers: Distribution by Company Size and Location of Headquarters (Region-wise)
Figure 7.6 Lab Automation Software Providers: Distribution by Type of Software
Figure 7.7 Lab Automation Software Providers: Distribution by Mode(s) of Deployment
Figure 7.8 Lab Automation Software Providers: Distribution by Type of Software and Mode(s) of Deployment
Figure 7.9 Lab Automation Software Providers: Distribution by End-user(s)
Figure 7.10 Lab Automation Software Providers: Distribution by Type of Software and End-user(s)
Figure 8.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 8.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Automation Instrument(s) Used
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Local and International Agreements
Figure 8.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.1 Patent Analysis: Distribution by Patent Publication Year
Figure 9.2 Patent Analysis: Distribution by Publication Year and Type of Patent
Figure 9.3 Patent Analysis: Distribution by Application Year
Figure 9.4 Patent Analysis: Distribution by Patent Jurisdiction
Figure 9.5 Patent Analysis: Distribution by CPC Symbols
Figure 9.6 Patent Analysis: Cumulative Distribution by Type of Applicant
Figure 9.7 Word Cloud: Emerging Focus Areas
Figure 9.8 Patent Analysis: Distribution by Patent Age
Figure 9.9 Leading Industry Players: Distribution by Number of Patents
Figure 9.10 Leading Non-Industry Players: Distribution by Number of Patents
Figure 9.11 Leading Individual Assignees: Distribution by Number of Patents
Figure 9.12 Patent Benchmarking: Distribution of Leading Industry Players by Patent Characterization (CPC Symbols)
Figure 9.13 Patent Valuation: Distribution by Relative Patent Valuation
Figure 10.1. Global Lab Automation Market, 2023-2035 (USD Billion)
Figure 10.2. Global Lab Automation Market: Distribution by Stage of Automation, 2023 and 2035
Figure 10.3. Lab Automation Market for Pre-analytical Stage, 2023-2035 (USD Million)
Figure 10.4. Lab Automation Market for Analytical Stage, 2023-2035 (USD Million)
Figure 10.5. Lab Automation Market for Post-analytical Stage, 2023-2035 (USD Million)
Figure 10.6. Lab Automation Market for Total Lab Automation, 2023-2035 (USD Million)
Figure 10.7. GlobalLab Automation Market: Distribution by Type of Instrument, 2023 and 2035
Figure 10.8. Lab Automation Market for Automated Liquid Handling Systems, 2023-2035 (USD Million)
Figure 10.9. Lab Automation Market for Automated Microplate Readers, 2023-2035 (USD Million)
Figure 10.10. Lab Automation Market for Automated Sampling Systems, 2023-2035 (USD Million)
Figure 10.11. Lab Automation Market for Analyzers, 2023-2035 (USD Million)
Figure 10.12. Lab Automation Market for Automated Storage and Retrieval Systems (ASRS), 2023-2035 (USD Million)
Figure 10.13. Lab Automation Market for Other Instruments, 2023-2035 (USD Million)
Figure 10.14. GlobalLab Automation Market: Distribution by Application, 2023 and 2035
Figure 10.15. Lab Automation Market for Diagnostics, 2023-2035 (USD Million)
Figure 10.16. Lab Automation Market for Genomic Solutions, 2023-2035 (USD Million)
Figure 10.17. Lab Automation Market for Microbiology, 2023-2035 (USD Million)
Figure 10.18. Lab Automation Market for Drug Discovery, 2023-2035 (USD Million)
Figure 10.19. Lab Automation Market for Proteomic Solutions, 2023-2035 (USD Million)
Figure 10.20. Lab Automation Market for Other Applications, 2023-2035 (USD Million)
Figure 10.21. Global Lab Automation Market: Distribution by End-user, 2023 and 2035
Figure 10.22. Lab Automation Market for Research and Diagnostic Laboratories, 2023-2035 (USD Million)
Figure 10.23. Lab Automation Market for Biotechnology and Pharmaceutical Industries, 2023-2035 (USD Million)
Figure 10.24. Lab Automation Market for Other End-users, 2023-2035 (USD Million)
Figure 10.25. Global Lab Automation Market: Distribution by Key Geographical Regions, 2023 and 2035
Figure 10.26. Lab Automation Market in North America, 2023-2035 (USD Million)
Figure 10.27. Lab Automation Market in Europe, 2023-2035 (USD Million)
Figure 10.28. Lab Automation Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 10.29. Lab Automation Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 10.30. Lab Automation Market in Latin America, 2023-2035 (USD Million)
Table 4.1 Lab Automation System Manufacturers: Information on Year of Establishment, Company Size and Location of Headquarters
Table 4.2 Lab Automation System Manufacturers: Information on Type of Automated Instrument(s)
Table 4.3 Lab Automation System Manufacturers: Information on Stage(s) of Automation, Application Area(s) and End-user(s)
Table 6.1 Abbott: Lab Automation Products
Table 6.2 Abbott: Recent Developments and Future Outlook
Table 6.3 Anton Paar: Lab Automation Products
Table 6.4 Anton Paar: Future Outlook
Table 6.5 BD: Lab Automation Products
Table 6.6 BD: Recent Developments and Future Outlook
Table 6.7 Beckman Coulter: Lab Automation Products
Table 6.8 Beckman Coulter: Recent Developments and Future Outlook
Table 6.9 ERWEKA: Lab Automation Products
Table 6.10 ERWEKA: Recent Developments and Future Outlook
Table 6.11 Leuze: Lab Automation Products
Table 6.12 Leuze: Recent Developments and Future Outlook
Table 6.13 Ortho Clinical Diagnostics: Lab Automation Products
Table 6.14 Ortho Clinical Diagnostics: Recent Developments and Future Outlook
Table 6.15 Pall Corporation: Lab Automation Products
Table 6.16 Pall Corporation: Recent Developments and Future Outlook
Table 6.17 PerkinElmer: Lab Automation Products
Table 6.18 PerkinElmer: Recent Developments and Future Outlook
Table 6.19 Roche Diagnostics: Lab Automation Products
Table 6.20 Roche Diagnostics: Recent Developments and Future Outlook
Table 6.21 Siemens Healthineers: Lab Automation Products
Table 6.22 Siemens Healthineers: Recent Developments and Future Outlook
Table 6.23 SYSTAG: Lab Automation Products
Table 6.24 SYSTAG: Recent Developments and Future Outlook
Table 7.1 Lab Automation Software Providers: Information on Location of Headquarters, Company Size, Type of Software, Mode(s) of Deployment and End-User(s)
Table 8.1 Lab Automation: List of Partnerships and Collaborations
Table 9.1 Lab Automation: List of Filed / Granted Patents
Table 9.2 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 12.1 Lab Automation System Manufacturers: Distribution by Year of Establishment
Table 12.2 Lab Automation System Manufacturers: Distribution by Company Size
Table 12.3 Lab Automation System Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 12.4 Lab Automation System Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 12.5 Lab Automation System Manufacturers: Distribution by Company Size and Location of Headquarters (Region-wise)
Table 12.6 Lab Automation System Manufacturers: Distribution by Type of Lab Automation system(s)
Table 12.7 Lab Automation System Manufacturers: Distribution by Type of Automated Liquid Handling System(s)
Table 12.8 Lab Automation System Manufacturers: Distribution by Type of Automated Microplate(s)
Table 12.9 Lab Automation System Manufacturers: Distribution by Stage(s) of Automation
Table 12.10 Lab Automation System Manufacturers: Distribution by Application Area(s)
Table 12.11 Lab Automation System Manufacturers: Distribution by Type of Lab Automation System(s) and Application Area(s)
Table 12.12 Lab Automation System Manufacturers: Distribution by End-user(s)
Table 12.13 Lab Automation System Manufacturers: Distribution by Stage(s) of Automation and End-user(s)
Table 12.14 Abbott: Annual Revenues, 2018-2022 (USD Billion)
Table 12.15 BD: Annual Revenues, FY 2018-Q1 FY 2023 (USD Billion)
Table 12.16 Danaher (parent company of Beckman Coulter): Annual Revenues, FY 2018-FY 2022 (USD Billion)
Table 12.17 Ortho Clinical Diagnostics: Annual Revenues, FY 2019-FY 2022 (USD Billion)
Table 12.18 Danaher (parent company of Pall Corporation): Annual Revenues, FY 2018-FY 2022 (USD Billion)
Table 12.19 PerkinElmer: Annual Revenues, FY 2018-FY 2022 (USD Billion)
Table 12.20 Roche Diagnostics: Annual Revenues, FY 2018-FY 2022 (CHF Billion)
Table 12.21 Siemens Healthineers: Annual Revenues, FY 2018-Q1 FY 2023 (USD Billion)
Table 12.22 Lab Automation Software Providers: Distribution by Year of Establishment
Table 12.23 Lab Automation Software Providers: Distribution by Company Size
Table 12.24 Lab Automation Software Providers: Distribution by Location of Headquarters (Region-wise)
Table 12.25 Lab Automation Software Providers: Distribution by Location of Headquarters (Country-wise)
Table 12.26 Lab Automation Software Providers: Distribution by Company Size and Location of Headquarters (Region-wise)
Table 12.27 Lab Automation Software Providers: Distribution by Type of Software
Table 12.28 Lab Automation Software Providers: Distribution by Mode(s) of Deployment
Table 12.29 Lab Automation Software Providers: Distribution by Type of Software and Mode(s) of Deployment
Table 12.30 Lab Automation Software Providers: Distribution by End-user(s)
Table 12.31 Lab Automation Software Providers: Distribution by Type of Software and End-user(s)
Table 12.32 Partnerships and Collaborations: Distribution by Year of Partnership
Table 12.33 Partnerships and Collaborations: Distribution by Type of Partnership
Table 12.34 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 12.35 Partnerships and Collaborations: Distribution by Type of Partner
Table 12.36 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 12.37 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 12.38 Partnerships and Collaborations: Distribution by Type of Automation Instrument(s)
Table 12.39 Most Active Players: Distribution by Number of Partnerships
Table 12.40 Partnerships and Collaborations: Local and International Agreements
Table 12.41 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 12.42 Patent Analysis: Distribution by Patent Publication Year
Table 12.43 Patent Analysis: Distribution by Publication Year and Type of Patent
Table 12.44 Patent Analysis: Distribution by Application Year
Table 12.45 Patent Analysis: Distribution by Patent Jurisdiction
Table 12.46 Patent Analysis: Distribution in Asia-Pacific and Rest of the World
Table 12.47 Patent Analysis: Distribution of Patents in China by Type of Applicant
Table 12.48 Patent Analysis: List of Top CPC Symbols
Table 12.49 Patent Analysis: Cumulative Distribution by Type of Applicant
Table 12.50 Patent Analysis: Distribution by Patent Age
Table 12.51 Leading Industry Players: Distribution by Number of Patents
Table 12.52 Leading Non-Industry Players: Distribution by Number of Patents
Table 12.53 Leading Individual Assignees: Distribution by Number of Patents
Table 12.54 Patent Valuation: Distribution by Relative Patent Valuation
Table 12.55 Global Lab Automation Market: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 12.56 Lab Automation Market: Distribution by Stage of Automation, 2023 and 2035
Table 12.57 Lab Automation Market for Pre-analytical Stage: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.58 Lab Automation Market for Analytical Stage: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.59 Lab Automation Market for Post-analytical Stage: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.60 Lab Automation Market for Total Lab Automation: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.61 Lab Automation Market: Distribution by Type of Instrument, 2023 and 2035
Table 12.62 Lab Automation Market for Automated Liquid Handling Systems: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.63 Lab Automation Market for Automated Microplate Readers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.64 Lab Automation Market for Automated Sampling Systems: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.65 Lab Automation Market for Analyzers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.66 Lab Automation Market for Automated Storage and Retrieval Systems (ASRS): Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.67 Lab Automation Market for Other Instruments: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.68 Lab Automation Market: Distribution by Application, 2023 and 2035
Table 12.69 Lab Automation Market for Diagnostics: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.70 Lab Automation Market for Genomic Solutions: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.71 Lab Automation Market for Microbiology: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.72 Lab Automation Market for Drug Discovery: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.73 Lab Automation Market for Proteomic Solutions: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.74 Lab Automation Market for Other Applications: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.75 Lab Automation Market: Distribution by End-user, 2023 and 2035
Table 12.76 Lab Automation Market for Research and Diagnostic Laboratories: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.77 Lab Automation Market for Biotechnology and Pharmaceutical Industries: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.78 Lab Automation Market for Other End-users: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.79 Lab Automation Market: Distribution by Key Geographical Regions, 2023 and 2035
Table 12.80 Lab Automation Market in North America: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.81 Lab Automation Market in Europe: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.82 Lab Automation Market in Asia-Pacific: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.83 Lab Automation Market in Middle East and North Africa: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 12.84 Lab Automation Market in Latin America: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
The following companies / institutes / government bodies and organizations have been mentioned in this report:
Source 1: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725284/